Theravance Biopharma (TBPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Theravance Bio (TBPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming…
Theravance Biopharma to Present New Ampreloxetine Data in Neurogenic Orthostatic Hypotension at the 33rd International Symposium on the Autonomic Nervous System DUBLIN, Oct. 25, 2022 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced new ampreloxetine…